Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Pharmacoepidemiology and Drug Safety
|
May 30, 2014
Use of an active surveillance system by the FDA to observe patterns of quinine sulfate use and adverse hematologic outcomes in CMS Medicare data
Monika Houstoun, Marsha E Reichman, David J Graham, et al.
Contemporary Clinical Trials Communications
|
April 27, 2018
Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation Initiative
Rachel G Greenberg, Amy Corneli, John Bradley, et al.
Nature Microbiology
|
April 9, 2025
Author Correction: Combining antibiotics to tackle antimicrobial resistance
William Hope, Sumathi Nambiar, Seamus O'Brien, et al.
Nature Microbiology
|
March 27, 2025
Combining antibiotics to tackle antimicrobial resistance
William Hope, Sumathi Nambiar, Seamus O'Brien, et al.
Open Forum Infectious Diseases
|
June 24, 2026
Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections
Jessica Howard-Anderson, Toshimitsu Hamasaki, Lizhao Ge, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 23, 2023
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Jessica Howard-Anderson, Toshimitsu Hamasaki, Weixiao Dai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 28, 2022
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials
Jessica Howard-Anderson, Toshimitsu Hamasaki, Weixiao Dai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 15, 2021
FDA Public Workshop Summary-Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs
Elizabeth O'Shaughnessy, Yuliya Yasinskaya, Cheryl Dixon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 6, 2023
Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical Need
Yuliya Yasinskaya, Shukal Bala, Ursula Waack, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 6, 2023
Food and Drug Administration Public Workshop Summary-Addressing Challenges in Inhaled Antifungal Drug Development
Caroline J Jjingo, Shukal Bala, Ursula Waack, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Pharmacoepidemiology and Drug Safety
|
May 30, 2014
Use of an active surveillance system by the FDA to observe patterns of quinine sulfate use and adverse hematologic outcomes in CMS Medicare data
Monika Houstoun, Marsha E Reichman, David J Graham, et al.
Contemporary Clinical Trials Communications
|
April 27, 2018
Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation Initiative
Rachel G Greenberg, Amy Corneli, John Bradley, et al.
Nature Microbiology
|
April 9, 2025
Author Correction: Combining antibiotics to tackle antimicrobial resistance
William Hope, Sumathi Nambiar, Seamus O'Brien, et al.
Nature Microbiology
|
March 27, 2025
Combining antibiotics to tackle antimicrobial resistance
William Hope, Sumathi Nambiar, Seamus O'Brien, et al.
Open Forum Infectious Diseases
|
June 24, 2026
Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections
Jessica Howard-Anderson, Toshimitsu Hamasaki, Lizhao Ge, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 23, 2023
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Jessica Howard-Anderson, Toshimitsu Hamasaki, Weixiao Dai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 28, 2022
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials
Jessica Howard-Anderson, Toshimitsu Hamasaki, Weixiao Dai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 15, 2021
FDA Public Workshop Summary-Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs
Elizabeth O'Shaughnessy, Yuliya Yasinskaya, Cheryl Dixon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 6, 2023
Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical Need
Yuliya Yasinskaya, Shukal Bala, Ursula Waack, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 6, 2023
Food and Drug Administration Public Workshop Summary-Addressing Challenges in Inhaled Antifungal Drug Development
Caroline J Jjingo, Shukal Bala, Ursula Waack, et al.
Page
of 5